Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Quan

Showing results (661-670 of 691) with videos related to

Pageof 70
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|June 10, 2020
Circulating extracellular vesicles from patients with valvular heart disease induce neutrophil chemotaxis via FOXO3a and the inhibiting role of dexmedetomidineHao-Xiang Yuan, Cai-Yun Chen, Yu-Quan Li, et al.
Oncology|August 10, 2005
Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activitiesJian-Mei Hou, Ji-Yan Liu, Li Yang, et al.
Journal of Molecular and Cellular Cardiology|February 25, 2019
Overexpression of inducible nitric oxide synthase in the diabetic heart compromises ischemic postconditioningTian-Tian Wang, Mao-Mao Shi, Xiao-Long Liao, et al.
Scientific Reports|March 31, 2016
Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplexZhi-Yao He, Feng Deng, Xia-Wei Wei, et al.
The Journal of Biological Chemistry|March 26, 2003
Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in miceQiu-ming He, Yu-quan Wei, Ling Tian, et al.
Cancer Research|February 5, 2003
Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2Jing-Mei Su, Yu-Quan Wei, Ling Tian, et al.
Journal of Medicinal Chemistry|April 4, 2015
Design, Synthesis, and Structure-Activity Relationship Studies of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as a New Class of Src Inhibitors with Potent Activities in Models of Triple Negative Breast CancerChun-Hui Zhang, Ming-Wu Zheng, Ya-Ping Li, et al.
BMJ Open|March 12, 2022
Rationale and design for comparison of non-compliant balloon with drug-coating balloon angioplasty for side branch after provisional stenting for patients with true coronary bifurcation lesions: a prospective, multicentre and randomised DCB-BIF trialXiao-Fei Gao, Zhen Ge, Jing Kan, et al.
Journal of Medicinal Chemistry|March 29, 2012
Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivoWei-Wei Li, Xiao-Yan Wang, Ren-Lin Zheng, et al.
Oncotarget|February 10, 2018
Betulinic acid impairs metastasis and reduces immunosuppressive cells in breast cancer modelsAn-Qi Zeng, Yan Yu, Yu-Qin Yao, et al.
Pageof 70

Showing results (661-670 of 691) with videos related to

Sort By:
Pageof 70
American Journal of Physiology. Endocrinology and Metabolism|June 10, 2020
Circulating extracellular vesicles from patients with valvular heart disease induce neutrophil chemotaxis via FOXO3a and the inhibiting role of dexmedetomidineHao-Xiang Yuan, Cai-Yun Chen, Yu-Quan Li, et al.
Oncology|August 10, 2005
Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activitiesJian-Mei Hou, Ji-Yan Liu, Li Yang, et al.
Journal of Molecular and Cellular Cardiology|February 25, 2019
Overexpression of inducible nitric oxide synthase in the diabetic heart compromises ischemic postconditioningTian-Tian Wang, Mao-Mao Shi, Xiao-Long Liao, et al.
Scientific Reports|March 31, 2016
Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplexZhi-Yao He, Feng Deng, Xia-Wei Wei, et al.
The Journal of Biological Chemistry|March 26, 2003
Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in miceQiu-ming He, Yu-quan Wei, Ling Tian, et al.
Cancer Research|February 5, 2003
Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2Jing-Mei Su, Yu-Quan Wei, Ling Tian, et al.
Journal of Medicinal Chemistry|April 4, 2015
Design, Synthesis, and Structure-Activity Relationship Studies of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as a New Class of Src Inhibitors with Potent Activities in Models of Triple Negative Breast CancerChun-Hui Zhang, Ming-Wu Zheng, Ya-Ping Li, et al.
BMJ Open|March 12, 2022
Rationale and design for comparison of non-compliant balloon with drug-coating balloon angioplasty for side branch after provisional stenting for patients with true coronary bifurcation lesions: a prospective, multicentre and randomised DCB-BIF trialXiao-Fei Gao, Zhen Ge, Jing Kan, et al.
Journal of Medicinal Chemistry|March 29, 2012
Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivoWei-Wei Li, Xiao-Yan Wang, Ren-Lin Zheng, et al.
Oncotarget|February 10, 2018
Betulinic acid impairs metastasis and reduces immunosuppressive cells in breast cancer modelsAn-Qi Zeng, Yan Yu, Yu-Qin Yao, et al.
Pageof 70